CHELSIE MIYAO: Open Payments
NPI 1659857779 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,469 in 56 payments from 24 companies in 2025. Trend: 2023 $32 · 2024 $184 · 2025 $1,469
Food & beverage: $1,363Education: $105
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $264 |
| Janssen Biotech, Inc. | 4 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $143 |
| Incyte Corporation | 2 | $113 |
| Daiichi Sankyo Inc. | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 6 | $96 |
| ABBVIE INC. | 4 | $81 |
| PFIZER INC. | 4 | $74 |
| Eisai Inc. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
Products named: Enhertu, TECVAYLI, IMFINZI, Lenvima, LIBTAYO, LUTATHERA, Vanflyta, EPKINLY.
Industry payments across AZ — which companies pay providers there.
